Resmed (RSMDF) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Powered by 
Analysis
Resmed (RSMDF) Net Income towards Common Stockholders Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 178.34 Bn | 7.27 Bn | -47.84% |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn | 23.94% |
| 3 | Medtronic | 118.22 Bn | 109.40 Bn | 6.34 Bn | 41.36% |
| 4 | Stryker | 104.52 Bn | 101.04 Bn | 4.50 Bn | 44.34% |
| 5 | Boston Scientific | 66.33 Bn | 65.79 Bn | 3.85 Bn | 13.80% |
| 6 | Edwards Lifesciences | 49.61 Bn | 45.35 Bn | 1.35 Bn | -27.18% |
| 7 | Alcon | 33.94 Bn | 32.49 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 38.54% |
| 9 | Steris | 21.13 Bn | 20.65 Bn | 684.20 Mn | 12.92% |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 0.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.98% |
| Mar 31, 2026 | 9.23% |
| Dec 31, 2025 | 13.92% |
| Sep 30, 2025 | 11.94% |
| Jun 30, 2025 | 29.93% |
| Mar 31, 2025 | 21.48% |
| Dec 31, 2024 | 65.05% |
| Sep 30, 2024 | 41.90% |
| Jun 30, 2024 | 27.25% |
| Mar 31, 2024 | 29.24% |
| Dec 31, 2023 | -7.16% |
| Sep 30, 2023 | 4.25% |
| Jun 30, 2023 | 17.74% |
| Mar 31, 2023 | 29.88% |
| Dec 31, 2022 | 11.48% |
| Sep 30, 2022 | 3.37% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | 328.10% |
| Dec 31, 2021 | 12.39% |
| Sep 30, 2021 | 14.15% |